ORTINLAB

ORTIN LABORATORIES

Small Cap BSE: 539287 NSE: ORTINLAB
₹22.75
-0.65 (-2.78%)
As on 10 December, 2022 | 06:41

Ortin Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in ORTIN LABORATORIES

Start SIP

Ortin Laboratories Share Price

Ortin Laboratories Share Returns

  • Over 1 Month -7.89%
  • Over 3 Month -3.81%
  • Over 6 Month -3.81%
  • Over 1 Year -27.08%

Ortin Laboratories Key Statistics

P/E Ratio -20.8
PEG Ratio 0.1
Market Cap Cr 19
Price to Book Ratio 1.7
EPS -0.5
Dividend 0
Relative Strength Index 46.68
Money Flow Index 68.73
MACD Signal -0.11
Average True Range 1

Ortin Laboratories Investment Rating

  • Master Rating:
  • Ortin Laboratories has an operating revenue of Rs. 7.36 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of -6% needs improvement, ROE of -3% is poor and needs improvement. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 32 which is a POOR score indicating inconsistency in earnings, a RS Rating of 24 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 129 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Ortin Laboratories Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 1322222
Operating Expenses Qtr Cr 1232222
Operating Profit Qtr Cr 0000000
Depreciation Qtr Cr 0000000
Interest Qtr Cr 0000000
Tax Qtr Cr 000000-1
Net Profit Qtr Cr 0000001

Ortin Laboratories Technicals

EMA & SMA

Current Price
22.75
-0.65 (-2.78%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 23
  • 50 Day
  • 23.16
  • 100 Day
  • 23.45
  • 200 Day
  • 24.38
  • 20 Day
  • 22.79
  • 50 Day
  • 23.18
  • 100 Day
  • 23.32
  • 200 Day
  • 23.94

Ortin Laboratories Resistance and Support

PIVOT
₹23.59
Resistance
First Resistance 24.32
Second Resistance 25.24
Third Resistance 25.97
RSI 46.68
MFI 68.73
MACD Single Line -0.11
MACD -0.06
Support
First Resistance 22.67
Second Resistance 21.94
Third Resistance 21.02

Ortin Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 23,235 1,658,747 71.39
Week 27,809 1,605,135 57.72
1 Month 42,589 2,313,454 54.32
6 Month 53,731 2,632,828 49

Ortin Laboratories Result Highlights

Ortin Laboratories Synopsis

NSE-Medical-Diversified

Ortin Laborator. belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 8.23 Cr. and Equity Capital is Rs. 8.13 Cr. for the Year ended 31/03/2022. Ortin Laboratories Ltd. is a Public Limited Listed company incorporated on 27/10/1986 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1986PLC006885 and registration number is 006885.
Market Cap 18
Sales 7
Shares in Float 0.68
No of funds
Yield
Book Value 1.69
U/D Vol ratio 1.4
LTDebt / Equity 16
Alpha -0.09
Beta 1.28

Ortin Laboratories

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 15.68%15.68%15.68%
Individual Investors 77.73%80.15%79.26%
Others 6.59%4.17%5.06%

Ortin Laboratories Management

Name Designation
Mr. J R K Panduranga Rao Chairman & Managing Director
Mr. S Murali Krishna Murthy Managing Director
Mr. S Srinivas Kumar WholeTime Director & CFO
Mr. G Venkata Ramana Non Executive Director
Mr. Bh Satyanarayana Raju Non Executive Director
Mr. S Balaji Venkateswarlu Non Executive Director
Mr. B Gopal Reddy Independent Director
Mr. Murali Krishna Rayaprolu Independent Director
Ms. Pottur Sujatha Independent Director

Ortin Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ortin Laboratories Corporate Action

Date Purpose Remarks
2022-11-14 Quarterly Results
2022-08-13 Quarterly Results
2022-05-30 Audited Results
2022-02-14 Quarterly Results
2021-11-13 Quarterly Results

Ortin Laboratories FAQs

What is Share Price of Ortin Laboratories ?

Ortin Laboratories share price is ₹22 As on 10 December, 2022 | 06:27

What is the Market Cap of Ortin Laboratories ?

The Market Cap of Ortin Laboratories is ₹18.5 Cr As on 10 December, 2022 | 06:27

What is the P/E ratio of Ortin Laboratories ?

The P/E ratio of Ortin Laboratories is -20.8 As on 10 December, 2022 | 06:27

What is the PB ratio of Ortin Laboratories ?

The PB ratio of Ortin Laboratories is 1.7 As on 10 December, 2022 | 06:27

Q2FY23